According to 2023 Patient Registry data, the median predicted age of survival for people with cystic fibrosis born between 2019-2023 is 61. While we are proud of this continued improvement, we recognize that this longer lifespan does not represent the experience for everyone with CF. We also know that quality of life — and not just quantity — is tremendously important. That’s why we’re working harder than ever to develop transformative treatments for all people with CF and support high-quality, specialized care across our care center network. Your support has helped us achieve this milestone — but there is more to do. We will never settle for less than curing CF.